Vitexin
Vitexin has antinociceptive and antispasmodic activities.Vitexin exhibits a prominent first-pass effect. Vitexin has antioxidant, antimyeloperoxidase, and α-glucosidase inhibitory activities. Vitexin can either inhibit or induce activities of CYP2C11 and CYP3A1. Vitexin induces the novel p53-dependent metastatic and apoptotic pathway. Vitexin protects brain against cerebral I/R injury, and this effect may be regulated by mitogen-activated protein kinase (MAPK) and apoptosis signaling pathways.
Product Specifications
CAS Number
3681-93-4
Product Name Alternative
Vitexin, Apigenin 8-C-glucoside
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 62.5 mg/mL (144.55 mM)
Smiles
C1=CC (=CC=C1C2=CC (=O) C3=C (O2) C (=C (C=C3O) O) C4C (C (C (C (O4) CO) O) O) O) O
Molecular Formula
C21H20O10
Molecular Weight
432.38
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-beta-D-glucopyranosyl-2- (4-hydroxyphenyl) -
Available Sizes
Explore Other Products
Browse additional items from our catalog
Rabbit anti-Escherichia coli (strain K12) YBIR Polyclonal Antibody
Porcine 14S,15R-Epoxyeicosatrienoic acid ELISA kit
1-Cyclopropyl-3-methyl-4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-pyrazole
1-Cyclopropyl-3-methyl-4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-pyrazole